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ABSTRACT 
Objective- The aim of the present study was to formulate and in- vitro study of glipizide liposphere by using melt dispersion technique. 
Methods- Glipizide Liposphere system composed of paraffin wax, Stearic acid as lipid phase and sodium lauryl sulphate as surfactant. 
Glipizide lipospheres were prepared by using melt dispersion technique. Formulation of Glipizide was evaluated such as organoleptic 
properties, particle size, drug content, entrapment efficiency in-vitro study and stability of the lipospheres. 
Result- The formation of glipizide lipospheres by using melt dispersion technique was done successfully. All the formulations have off- white 
in colour, characteristic odour and spherical shape. The formulation A4 has particle size 19.65 μm, drug content 84.93 %, entrapment 
efficiency 80.75 % and the percentage drug release was carried out by using USP type 2 dissolution apparatus in 6.8 pH phosphate buffer 
solution and drug release of glipizide lipospheres within 12 hrs was found to be 74.06 %.stability study of glipizide lipospheres revealed that 
the formulation was stable at 5oC ± 3oC. 
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Lipospheres were reported for the first time by Domb and 
Maniar as aqueous micro dispersion of solid water 
insoluble spherical microparticles of particle size between 
0.02 to 100 μm in diameter. Lipospheres are composed of a 
solid hydrophobic lipid core as triglycerides, stabilized by a 
layer of phospholipid molecules embedded on their 
surface. The internal core contains the bioactive compound 
dissolved or dispersed in the solid fat matrix in fig. 1.1,2 
 
Figure 1: Structure of Liposphere 
Around 40 to 70 % of chemical entities are poor water 
soluble. Several techniques like lyophilisation, drug 
micronization and microencapsulation used to enhance the 
dissolution profile of water insoluble drugs. Lipospheres 
are the most promising drug delivery for the water 
insoluble drugs. Lipids are used as common excipient and 
base in creams, ointments and flow modifier. Lipospheres 
drug delivery technique is suitable for oral, parenteral and 
topical drug delivery of bioactive compounds and used for 
the formulation of anti-inflammatory compounds, local 
anesthetics, antibiotics and anticancer agents, as well as 
carriers of vaccines and adjuvants.3 
Advantages 
 Liposphere exhibit enhanced physical stability due to 
avoidance of coalescence. 
 High dispersability in an aqueous medium. 
 Low cost of ingredients. 
 Ease of preparation and scale up. 
 High entrapment of hydrophobic drugs. 
 Controlled particle size. 
 Extended release of entrapped drug after a single 
injection. 
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 Static interface facilitates surface modification of 
carrier particles after solidification of the lipid matrix. 
 The liposphere particle size allows administration at 
many sites, including perineural, subcutaneous, or 
intramuscular locations. The small particle size of 
liposphere (< 20 μm) is hypothesized to be well 
tolerated by a single cell contact , whereas large 
particle size (> 50 μm ) are much more reactive due to 
attractive forces (e.g. Van der Waals).2,4 
Disadvantages 
 Different lipid modifications and colloidal species 
coexist that may cause differences in solubility and 
melting point of active and auxillary species. 
 Low drug loading capacity for hydrophilic proteins. 
 Variable kinetics of distribution processes. 
 High-pressure induced drug degradation. 
 Insufficient stability data 
 Toxic effects of organic residues after the production 
of polymers, 
 Lack of large industrial scale production.4 
Glipizide is a sulfonyl urea class that can decrease the blood 
glucose level in human body by stimulating the release of 
insulin from the pancreas. It is mainly used in patients with 
type 2 diabetes, who have failed diet and exercise therapy. 
It is absorbed from Gastrointestinal tract, having 80-100 % 
oral bioavaibility and have short half-life is around 3-4.7 
hrs that it be administered in two or three doses of 2.5 to 
10 mg per day. Here we work towards to control the 
plasma concentrations level of drug maintained throughout 
24 hours dosing interval with less peak trough fluctuation 
than that observed with twice a day dosing of immediate 
release Glipizide.5,6,7 Glipizide lipospheres are prepared by 
melt dispersion method which is one of the most used and 
best method for preparation of liposphere because it gives 
high entrapment efficiency with controlled particle size. 
MATERIALS AND METHODS 
Materials 
Glipizide was gifted by Roorkee Testing Laboratories, 
Roorkee, India. Sodium Lauryl Sulfate, Paraffin Wax, and 
Stearic Acid were purchased from CDH, and all other 
chemicals were used of analytical grade. 
Preparation Method 
The Glipizide lipospheres may be prepared by the method:-  
 Melt Dispersion Technique 
The lipidic physical mixture containing paraffin wax and 
stearic acid was prepared with glipizide. The physical 
mixture was melted at 70°C and then emulsified into a hot 
external aqueous phase maintained at 70°C containing 
sodium lauryl sulphate. The emulsion was mechanically 
stirred by using stirrer equipped with alternate impellers 
and maintained at 70°C. Then, the emulsion formulation 
was rapidly cooled to about 20°C by immersing the 
formulation into an ice bath and continuing the agitation to 
yield uniform dispersion of LS. The obtained LS was then 
washed with water and isolated by filtration through 42 
number whatman filter paper. 8, 9 
 






Lipid Phase Sodium Lauryl 





A1  20 20 20 40 30  
A2  20 20 30 50 30  
A3  20 30 20  50  30  
A4  20 30 30  60  30  
A5  20 40  20 60  30  
 
Evaluation of Lipospheres 
Determination of Organoleptic properties 
Glipizide liposphere batches were evaluated for 
organoleptic properties such as colour, odour and shape by 
visual observations. 
Particle Size Determination- 
Particle size analysis of glipizide-loaded lipospheres was 
performed by optical microscopy using a compound 
microscope. A small amount of dry lipospheres was 
suspended in purified water (10ml). The suspension was 
shaking for 10 seconds. A small drop of suspension thus 
obtained was placed on a clean glass slide. The slide 
containing lipospheres was mounted on the stage of the 
microscope and 100 particles were measured using a 
calibrated micrometer.10, 11 
Determination of drug content 
The drug content of glipizide lipospheres was determined 
by dissolving accurately 10 mg dried lipospheres in a 
mixture of 1:9 ratios of chloroform and methanol. Solution 
was sonicated for 5-10 min by using sonicator (Biomedica, 
BMI-599). Solution was filtered and analyzed for drug 
concentration by using UV visible spectrophotometer 
(Elico, UV SL-210) at wavelength of 225 nm. The drug 
content was determined by using the straight line 
equation.3 
Drug Entrapment Efficiency 
The entrapped drug concentration of glipizide liposphere 
was determined by lysis of the lipospheres with absolute 
alcohol and sonication. Accurately weighed amount of 
loaded lipospheres 50 mg was dissolved in 10 ml absolute 
alcohol and covered to prevent evaporation .The solution 
was sonicated for 15 min to obtain a clear solution. Take 1 
ml of this solution was added to 9 ml of absolute alcohol. 
The solution was sonicated for another 15 min. The 
entrapment efficiency was determined by UV-visible 
spectrophotometer (Elico, UV SL-210) after suitable 
dilution at the absorbance 223nm. The entrapment 
efficiency was determined by the following formula 1, 3, 11 
Percentage entrapment efficiency = [Amount of drug in 
lipospheres/ Initial amount of drug incorporated in 
formulation] × 100 
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In-vitro Drug Release  
In vitro drug release of glipizide from lipospheres was 
evaluated in phosphate buffer (pH 6.8). Capsules (cream 
colour and size no.3) were filled by accurate amount of 
lipospheres equivalent to 10mg of glipizide liposphere. 
Then transferred to the pre-warmed dissolution media and 
maintained at 37±0.5°C under stirring at 50rpm. Samples 
were withdrawn every hour up to 8 hrs and the volume 
was replaced immediately by fresh phosphate buffer. The 
sample solution was filtered and analyzed for glipizide 
content by measuring absorbance in UV-
Spectrophotometer at 223 nm.1, 3   
Table 2: Dissolution apparatus & parameters 
S. no.  Equipments  Parameters  
1.  Dissolution apparatus  USP type-2, paddle  
2.  Dissolution media  6.8 pH phosphate buffer  
3.  Volume of the media  900 ml  
4.  Blank solution  6.8 pH phosphate buffer  
5.  Sampling volume  10 ml every 1 hour  
6.  Rotation speed  50 rpm  
7.  Temperature  37±0.50c  
8.  λmax  223 nm  
 
Stability testing 
According to ICH and WHO guidelines stability study of 
glipizide lipospheres was carried out. Glipizide lipospheres 
was packed with aluminium foil and exhibit this to 
different temperature i.e., 5oC ± 3oC, 25 ± 2oC/ 60 ± 5% RH 
and 40 ± 2oC/ 75 ± 5% RH for a period of two months12. 
RESULTS AND DISCUSSION 
Determination of Organoleptic properties 
The organoleptic properties such as colour, odour and 
shape of glipizide liposphere batches were evaluated.  
Table 3: Organoleptic properties 
Organoleptic properties Result 
Colour Off-White 
odour Faint  
Shape  Spherical 
 
Particle Size Determination 
Glipizide lipospheres shows particle size distribution in the 
range of 13.22 μm for A1 batch to 25 μm for A5 batch.  
Determination of drug content 
Drug content is usually depends on encapsulation of drug 
in lipid, surfactants and method of preparation. 
Glipizide lipospheres shows drug content in the range from 
65.47 % for A1 batch to 79.63 % for A5 batch. The drug 
content of glipizide liposphere batch A4 was found to be 
84.93 %. 
Table 4: Particle Size Data of Lipospheres 
S. NO.  Average Particle Size (μM)  
A1  13.22   
A2  15.24  
A3  18.38  
A4  19 .65 
A5  22.54 
 
Table 5: % Drug Content 
S. NO.  Drug content (%) 
A1  65.47  
A2  69.35  
A3  75.43  
A4  84.93 
A5  79.63  
 
Drug Entrapment Efficiency 
The entrapment efficiency of the drug is important 
parameter. The method used for the preparation of the 
liposphere is playing the important role in the entrapment 
of drug. The commonly used technique for the formation of 
liposphere was melt dispersion technique. Glipizide 
liposphere shows entrapment efficiency in the range from 
68.21 for batch A1 to 74.64 for batch A5. The entrapment 
efficiency of glipizide liposphere batch A4 was found to be 
80.75. Batch A4 has the high entrapment efficiency among 
all five glipizide liposphere batches. 
Table 6: % Drug Entrapment Efficiency 
S. NO.  Drug Entrapment Efficiency (%) 
A1  68.21  
A2  70.45  
A3  72.73  
A4  80.75  
A5  74.64  
 
In-vitro drug release  
All batches of glipizide liposphere from A1 to A5 give a 
sustained drug release profile. Type 2 paddle dissolution 
apparatus used in the in-vitro drug release of glipizide 
lipospheres. All of the drug release could last 12 hrs. 
Release profile of the glipizide liposphere range from 83.04 
for batch A1 to 68.11 for batch A5. Batch A4 has the drug 
release 74.06. 
 
Table 7: In-vitro drug release 
Time  
(hours)  
% Drug Release  
A1 A2  A3  A4  A5  
2  3.14  2.89  2.89  2.21  3.08  
4  32.31  29.52  30.16  22.91  32.84  
6  49.24  49.02  41  45.45  47.27  
8  68.53  61.13  56.18  56.82  60.95  
10  81.82  78.06  74.05  72.46  66.53  
12  83.04  80.13  78.03  74.06  68.11  
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Figure 2: Release Profile of Various Formulations at pH 
6.8 Phosphate Buffer 
Stability testing 
According to ICH and WHO guidelines the optimized batch 
of glipizide lipospheres A4 was subjected for stability 
testing. Glipizide liposphere batch A4 was packed in 
aluminium foil paper and kept in the stability chamber for 
two month. After two month glipizide lipospheres were 
stable at 5oC ± 3oC and checked the particle size and 
entrapment efficiency. Particle size and entrapment 
efficiency was found to be 18.24 μm and 79.24 % 
respectively.  
CONCLUSION 
Glipizide containing liposphere were prepared and 
evaluated successfully by using melt dispersion method. 
The evaluated tests were carried out such as organoleptic 
properties, particle size, drug content, entrapment 
efficiency, in-vitro drug release and stability study. The 
optimized batch A4 was the best among all five batches and 
found potential for further development.  
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